Found 8 matching trials
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
PHASE2To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Location
K&S Professional Research Services
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
PHASE3The purpose of this study is to evaluate the long-term safety of SPD489 adm...
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
PHASE3This study will examine SPD489 in subjects aged 18-65 with major depressive...
Location
ResearchOne, Inc.
Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss
PHASE2This is a double-blind, single center, parallel group, placebo and active c...
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
PHASE3The purpose of this study is to determine if an investigational treatment i...
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia
PHASE3To assess the safety and efficacy of SPD489 low-dose and high-dose treatmen...
Location
Multiple Locations
Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant
PHASE2To evaluate the efficacy of SPD489 when used as augmentation to an antidepr...
Location
Pharmacology Research Institute (PRI)
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
PHASE3This study will examine SPD489 in subjects aged 18-65 with major depressive...
Location
Birmingham Research Group